ArticleFrontiers in veterinary science2026
First report of carbapenemase-producing bacteria from poultry farms in the United Arab Emirates: an emerging One Health threat.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Carbapenemase-producing bacteria represent a critical global public health threat, yet their presence and molecular characteristics in food animal production systems remain poorly understood. This study provides the first comprehensive report of carbapenemase-producing bacteria isolated from poultry farms in the United Arab Emirates, offering important One Health insights into emerging antimicrobial resistance risks at the human-animal-environment interface. Methods: A total of 77 samples were collected from broiler farmhouses and slaughterhouses belonging to two major poultry companies in Al Ain, United Arab Emirates, between June 2023 and April 2024. Isolates were screened on MacConkey agar supplemented with meropenem, and carbapenemase production was confirmed using the modified carbapenem inactivation method. Antimicrobial susceptibility testing was performed, followed by whole-genome sequencing for species identification, resistome and virulome characterization, plasmid profiling, and comparative genomic analysis. Results: Three isolates (3.9%) were confirmed as carbapenemase producers, two of which exhibited multidrug resistance. Whole-genome sequencing identified one Conclusion: This study documents the presence of carbapenemase-producing bacteria in poultry production systems in the UAE, including a high-risk
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.